Artificial Intelligence is everywhere, from shopping assistants on Amazon, to replacing search engines like Google. While ChatGPT might make it easy to put together a shopping list or travel plans, it ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the overlooked penny stocks to invest in. On January 12, Alec Stranahan, an analyst at Bank of America Securities, maintained a Hold rating on ...

Just when you thought the circular deals couldn’t get any more circular, OpenAI has invested in CEO Sam Altman’s brain computer interface (BCI) startup Merge Labs. Merge Labs, which defines itself as ...

OpenAI has invested in Merge Labs, a startup developing brain-computer interfaces (BCIs). The company raised a total of $252 million in seed funding, according to Bloomberg. OpenAI CEO Sam Altman is a ...

OpenAI CEO Sam Altman’s new brain-computer interface startup, Merge Labs, is being spun out of the Los Angeles–based nonprofit Forest Neurotech, according to a source with direct knowledge of the ...

Trump Media & Technology Group (DJT) and fusion power company TAE Technologies have entered a definitive merger deal to combine in an all-stock transaction valued at more than $6 billion. The ...

NEW YORK, Dec 15 (Reuters) - Winston & Strawn and Taylor Wessing said on Monday that they expect to combine in May 2026, adding to a wave of major transatlantic law firm tie-ups. The deal unites ...

China’s increasing economic footprint in Brazil, Latin America’s largest economy, is redefining the region’s balance of power. Once primarily a trading partner, China is now entrenching itself in the ...

Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is slated to report third-quarter 2025 results on Nov. 5, before the opening bell.

Some Catholic parishes in four northern New Jersey counties may be consolidated as soon as 2027, church officials said. The discussion in the Archdiocese of Newark is the latest challenge facing ...

Altman taps a leading researcher for his brain-computer interface startup, suggesting a much less invasive approach than Elon Musk’s Neuralink. Altman taps a leading researcher for his brain-computer ...